Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soluble HLA revisited.

William B Tabayoyong, Nicholas Zavazava

    Leukemia Research
    |July 25, 2006
    PubMed
    Summary
    This summary is machine-generated.

    This editorial reviews soluble human leukocyte antigens (sHLA), focusing on their connection to Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD). It discusses sHLA-G and clinical applications in NHL.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of toxicities for intravesical drugs in phase 1 bladder cancer trials.

    Cancer·2022
    Same author

    Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.

    European urology oncology·2019
    Same author

    Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease.

    European urology·2018
    Same author

    Helminth-Induced Production of TGF-β and Suppression of Graft-versus-Host Disease Is Dependent on IL-4 Production by Host Cells.

    Journal of immunology (Baltimore, Md. : 1950)·2018
    Same author

    Systematic Review on the Utilization of Maintenance Intravesical Chemotherapy in the Management of Non-muscle-invasive Bladder Cancer.

    European urology focus·2018
    Same author

    Tracking embryonic hematopoietic stem cells to the bone marrow: nanoparticle options to evaluate transplantation efficiency.

    Stem cell research & therapy·2018
    Same journal

    Multispecialty referral patterns to a clonal hematopoiesis clinic: Who, what, and why?

    Leukemia research·2026
    Same journal

    A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

    Leukemia research·2026
    Same journal

    FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

    Leukemia research·2026
    Same journal

    CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

    Leukemia research·2026
    Same journal

    Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

    Leukemia research·2026
    Same journal

    Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

    Leukemia research·2026
    See all related articles

    Area of Science:

    • Immunology
    • Oncology

    Background:

    • Soluble human leukocyte antigens (sHLA) are immune molecules found in circulation.
    • sHLA, particularly soluble HLA-G (sHLA-G), plays a role in immune regulation and has been implicated in various diseases.
    • Understanding sHLA levels is crucial for diagnosing and managing certain cancers.

    Discussion:

    • This editorial examines the relationship between sHLA levels and lymphoproliferative disorders such as Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD).
    • It reviews the significance of sHLA-G in recent research concerning its immunomodulatory functions.
    • The role of sHLA in solid organ tumors is also addressed, providing a broader context.

    Key Insights:

    • Albitar et al. present findings on the correlation between sHLA levels and NHL/HD.

    Related Experiment Videos

  • sHLA-G is highlighted for its potential as a biomarker in various cancers.
  • The clinical relevance of sHLA in NHL is explored, suggesting potential diagnostic or prognostic applications.

    • Outlook:

    • Further research into sHLA could lead to novel therapeutic strategies for lymphomas.
    • The clinical utility of sHLA measurements in NHL patient management warrants further investigation.
    • Continued exploration of sHLA in oncology may reveal new insights into tumor immunology and patient outcomes.